Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer.

van Rossum PS, van Lier AL, van Vulpen M, Reerink O, Lagendijk JJ, Lin SH, van Hillegersberg R, Ruurda JP, Meijer GJ, Lips IM.

Radiother Oncol. 2015 May 19. pii: S0167-8140(15)00236-4. doi: 10.1016/j.radonc.2015.04.027. [Epub ahead of print]

PMID:
26002307
2.

Reduced local immune response with continuous positive airway pressure during one-lung ventilation for oesophagectomy.

Verhage RJ, Croese AC, van Hillegersberg R.

Br J Anaesth. 2015 Jun;114(6):1009-10. doi: 10.1093/bja/aev130. No abstract available.

PMID:
25991750
3.

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC.

J Med Genet. 2015 Jun;52(6):361-374. doi: 10.1136/jmedgenet-2015-103094. Epub 2015 May 15. Review.

4.

Diagnostic performance of 18F-FDG and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis.

Goense L, van Rossum PS, Reitsma JB, Lam MG, Meijer GJ, van Vulpen M, Ruurda JP, van Hillegersberg R.

J Nucl Med. 2015 May 7. pii: jnumed.115.155580. [Epub ahead of print]

PMID:
25952733
5.

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.

Ayez N, van der Stok EP, de Wilt H, Radema SA, van Hillegersberg R, Roumen RM, Vreugdenhil G, Tanis PJ, Punt CJ, Dejong CH, Jansen RL, Verheul HM, de Jong KP, Hospers GA, Klaase JM, Legdeur MC, van Meerten E, Eskens FA, van der Meer N, van der Holt B, Verhoef C, Grünhagen DJ.

BMC Cancer. 2015 Mar 26;15:180. doi: 10.1186/s12885-015-1199-8.

6.

The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.

Prins MJ, Ruurda JP, Lolkema MP, Sitarz R, Kate Ten FJ, van Hillegersberg R.

J Clin Pathol. 2015 Apr 8. pii: jclinpath-2015-202962. doi: 10.1136/jclinpath-2015-202962. [Epub ahead of print]

PMID:
25855799
7.

Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands.

Haverkamp L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, Bonenkamp JJ, Bisseling TM, Siersema PD, Sosef MN, Stoot JH, Beets GL, de Steur WO, Hartgrink HH, Verspaget HW, van der Peet DL, Plukker JT, van Etten B, Wijnhoven BP, van Lanschot JJ, van Hillegersberg R, Ruurda JP.

Dis Esophagus. 2015 Mar 30. doi: 10.1111/dote.12347. [Epub ahead of print]

PMID:
25824294
8.

Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.

van der Sluis PC, Ubink I, van der Horst S, Boonstra JJ, Voest EE, Ruurda JP, Borel Rinkes IH, Wiezer MJ, Schipper ME, Siersema PD, Los M, Lolkema MP, van Hillegersberg R.

Ann Surg Oncol. 2015 May;22(5):1555-63. doi: 10.1245/s10434-014-4120-9. Epub 2015 Jan 7.

PMID:
25564156
9.

Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer.

Rombouts SJ, Vogel JA, van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR, Besselink MG, Molenaar IQ.

Br J Surg. 2015 Feb;102(3):182-93. doi: 10.1002/bjs.9716. Epub 2014 Dec 18. Review.

PMID:
25524417
10.

Leaving a mobilized thoracic esophagus in situ when incurable cancer is discovered intraoperatively.

Weijs TJ, Toxopeus EL, Ruurda JP, Luyer MD, Nieuwenhuijzen GA, Schraepen MC, Sosef MN, Wijnhoven BP, Schets IR, Bleys RL, van Hillegersberg R.

Ann Thorac Surg. 2015 Feb;99(2):490-4. doi: 10.1016/j.athoracsur.2014.08.041. Epub 2014 Dec 10.

PMID:
25499476
11.

A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy.

Cuesta MA, Weijs TJ, Bleys RL, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Ruurda JP, Straatman J, Osugi H, van der Peet DL.

Surg Endosc. 2014 Dec 6. [Epub ahead of print]

PMID:
25480608
12.

Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction.

Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R.

Surg Oncol. 2014 Dec;23(4):222-8. doi: 10.1016/j.suronc.2014.10.004. Epub 2014 Oct 29. Review.

PMID:
25466852
13.

Neoadjuvant chemoradiotherapy for stage I and II esophageal cancer.

van Rossum PS, van Hillegersberg R, Reerink O, Ruurda JP.

J Clin Oncol. 2015 Jan 20;33(3):287-8. doi: 10.1200/JCO.2014.58.1272. Epub 2014 Dec 1. No abstract available.

PMID:
25452449
14.

Surgical treatments for esophageal cancers.

Allum WH, Bonavina L, Cassivi SD, Cuesta MA, Dong ZM, Felix VN, Figueredo E, Gatenby PA, Haverkamp L, Ibraev MA, Krasna MJ, Lambert R, Langer R, Lewis MP, Nason KS, Parry K, Preston SR, Ruurda JP, Schaheen LW, Tatum RP, Turkin IN, van der Horst S, van der Peet DL, van der Sluis PC, van Hillegersberg R, Wormald JC, Wu PC, Zonderhuis BM.

Ann N Y Acad Sci. 2014 Sep;1325:242-68. doi: 10.1111/nyas.12533.

PMID:
25266029
15.

Therapeutic approaches to gastroesophageal junction adenocarcinomas.

Blom RL, Bogush T, Brücher BL, Chang AC, Davydov M, Dudko E, Leong T, Polotsky B, Swanson PE, van Rossum PS, Ruurda JP, Sagaert X, Tjulandin S, Schraepen MC, Sosef MN, van Hillegersberg R.

Ann N Y Acad Sci. 2014 Sep;1325:197-210. doi: 10.1111/nyas.12532.

PMID:
25266026
16.

Prediction of positive resection margins in patients with non-palpable breast cancer.

Barentsz MW, Postma EL, van Dalen T, van den Bosch MA, Miao H, Gobardhan PD, van den Hout LE, Pijnappel RM, Witkamp AJ, van Diest PJ, van Hillegersberg R, Verkooijen HM.

Eur J Surg Oncol. 2015 Jan;41(1):106-12. doi: 10.1016/j.ejso.2014.08.474. Epub 2014 Sep 2.

PMID:
25228054
17.

Surgical treatment of adenocarcinomas of the gastro-esophageal junction.

Parry K, Haverkamp L, Bruijnen RC, Siersema PD, Ruurda JP, van Hillegersberg R.

Ann Surg Oncol. 2015 Feb;22(2):597-603. doi: 10.1245/s10434-014-4047-1. Epub 2014 Sep 5.

PMID:
25190126
18.

Imaging of oesophageal cancer with FDG-PET/CT and MRI.

van Rossum PS, van Lier AL, Lips IM, Meijer GJ, Reerink O, van Vulpen M, Lam MG, van Hillegersberg R, Ruurda JP.

Clin Radiol. 2015 Jan;70(1):81-95. doi: 10.1016/j.crad.2014.07.017. Epub 2014 Aug 27. Review.

PMID:
25172205
19.

Surgical techniques to prevent delayed gastric emptying after esophagectomy with gastric interposition: a systematic review.

Akkerman RD, Haverkamp L, van Hillegersberg R, Ruurda JP.

Ann Thorac Surg. 2014 Oct;98(4):1512-9. doi: 10.1016/j.athoracsur.2014.06.057. Epub 2014 Aug 22. Review.

PMID:
25152385
20.

Calcification of arteries supplying the gastric tube: a new risk factor for anastomotic leakage after esophageal surgery.

van Rossum PS, Haverkamp L, Verkooijen HM, van Leeuwen MS, van Hillegersberg R, Ruurda JP.

Radiology. 2015 Jan;274(1):124-32. doi: 10.1148/radiol.14140410. Epub 2014 Aug 11.

PMID:
25119021
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk